Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood filtering treatment tested for nerve disorders in egyptian patients

NCT ID NCT07197099

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 40 times

Summary

This study looks at how well therapeutic plasma exchange (a blood-filtering procedure) works for people with autoimmune neurological diseases. Researchers at Al-Azhar University Hospitals will follow 60 Egyptian patients to see if their symptoms and daily function improve. The goal is to gather real-world evidence on this treatment's effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROLOGICAL AUTOIMMUNE DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Al-Azhar University Hospitals

    RECRUITING

    Cairo, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

therapeutic plasma exchange (a procedure that filters the blood to remove harmful antibodies)

What this could lead to

If successful, this could show that plasma exchange is a useful treatment option for certain neurological autoimmune diseases in Egyptian patients.

What could go wrong

This is an observational study with only 60 participants, so results may not apply to all patients. There are also risks like allergic reactions or low blood pressure during the procedure.

Conditions

The condition(s) this trial relates to.

autoimmune disorder of the nervous system

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.